Primary Site >> Liver Cancer

Gene >> PDCD1

Journal: Cancer Res. 2009 Oct 15;69(20):8067-75.
Title: Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions.
Author: Wu, Ke|Kryczek, Ilona|Chen, Lieping|Zou, Weiping|Welling, Theodore H
PMID: 19826049
Journal: Gene. 2012 Dec 15;511(2):308-13.
Title: Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: a case-control study.
Author: Bayram, Suleyman|Akkiz, Hikmet|Ulger, Yakup|Bekar, Aynur|Akgollu, Ersin|Yildirim, Selcuk
PMID: 23041554
Journal: Infect Genet Evol. 2013 Mar;14:240-6.
Title: Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.
Author: Li, Zhu|Li, Na|Zhu, Qianqian|Zhang, Guoyu|Han, Qunying|Zhang, Pingping|Xun, Meng|Wang, Yawen|Zeng, Xiaoyan|Yang, Cuiling|Liu, Zhengwen
PMID: 23291409
Journal: Immunol Lett. 2014 Nov;162(1 Pt A):212-6.
Title: PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated region polymorphism in patients with chronic HBV infection.
Author: Zhang, Guoyu|Li, Na|Zhang, Pingping|Li, Fang|Yang, Cuiling|Zhu, Qianqian|Han, Qunying|Lv, Yi|Zhou, Zhihua|Liu, Zhengwen
PMID: 25218665
Journal: Oncotarget. 2015 Aug 7;6(22):18933-44.
Title: microRNA-4717 differentially interacts with its polymorphic target in the PD1 3' untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases.
Author: Zhang, Guoyu|Li, Na|Li, Zhu|Zhu, Qianqian|Li, Fang|Yang, Cuiling|Han, Qunying|Lv, Yi|Zhou, Zhihua|Liu, Zhengwen
PMID: 25895129
Journal: Sci Rep. 2017 May 26;7(1):2452.
Title: Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging.
Author: Hectors, Stefanie J|Wagner, Mathilde|Bane, Octavia|Besa, Cecilia|Lewis, Sara|Remark, Romain|Chen, Nelson|Fiel, M Isabel|Zhu, Hongfa|Gnjatic, Sacha|Merad, Miriam|Hoshida, Yujin|Taouli, Bachir
PMID: 28550313
Journal: Int J Oncol. 2018 Jun;52(6):2079-2092.
Title: Expression and clinical significance of PD1 in hepatocellular carcinoma tissues detected by a novel mouse anti-human PD1 monoclonal antibody.
Author: Li, Ziwei|Li, Bin|Peng, Dan|Xing, Haiyan|Wang, Guanying|Li, Pan|Wang, Jiming|Ye, George|Chen, Jianhong
PMID: 29620156
Journal: Cancer Immunol Immunother. 2018 Aug 4. pii: 10.1007/s00262-018-2221-1.
Title: Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein.
Author: Pan, Zeyan|Di, Shengmeng|Shi, Bizhi|Jiang, Hua|Shi, Zhimin|Liu, Ying|Wang, Yi|Luo, Hong|Yu, Min|Wu, Xiuqi|Li, Zonghai
PMID: 30078052
Journal: Gastroenterology. 2018 Aug 23. pii: S0016-5085(18)34897-2.
Title: Association Between Expression Level of PD1 by Tumor-Infiltrating CD8(+) T Cells and Features of Hepatocellular Carcinoma.
Author: Kim, Hyung-Don|Song, Gi-Won|Park, Seongyeol|Jung, Min Kyung|Kim, Min Hwan|Kang, Hyo Jeong|Yoo, Changhoon|Yi, Kijong|Kim, Kyung Hwan|Eo, Sukyeong|Moon, Deok-Bog|Hong, Seung-Mo|Ju, Young Seok|Shin, Eui-Cheol|Hwang, Shin|Park, Su-Hyung
PMID: 30145359
Journal: Semin Liver Dis. 2018 Nov;38(4):379-388.
Title: Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy.
Author: Lin, Yu-Yang|Tan, Ching-Ting|Chen, Chia-Wei|Ou, Da-Liang|Cheng, Ann-Lii|Hsu, Chiun
PMID: 30357775